 |
The Journal of Neuroscience, July 20, 2005, 25(29):6721-6728; doi:10.1523/JNEUROSCI.0760-05.2005
Previous Article | Next Article 
Neurobiology of Disease
Bcl-x Is Required for Proper Development of the Mouse Substantia Nigra
Joseph M. Savitt,1,2
Susie S. Jang,1
Weitong Mu,5
Valina L. Dawson,1,2,3,4 and
Ted M. Dawson1,2,3
1Institute for Cell Engineering and Departments of 2Neurology, 3Neuroscience, 4Physiology, and 5Internal Medicine, Division of Gastroenterology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
Recent findings have uncovered a role for the Bcl-x gene in the survival of dopaminergic neurons. The exact nature of this role has been difficult to examine because of the embryonic lethality of Bcl-x gene disruption in mouse models. Here we report the generation catecholaminergic cell-specific conditional Bcl-x gene knock-out mice using Cre-lox recombination technology. First we produced transgenic mice that express Cre recombinase from an exogenous rat tyrosine hydroxylase promoter (TH-Cre mice). These mice were crossed to Z/AP and Z/EG reporter mouse strains to verify catecholaminergic (TH-positive) cell-specific Cre expression. The TH-Cre mice then were mated to mice possessing the Bcl-x gene flanked by loxP sites, thereby producing offspring with Bcl-x deletion limited to catecholaminergic cells. The resulting mice are viable but have one-third fewer catecholaminergic neurons than do control animals. They demonstrate a deficiency in striatal dopamine and also tend to be smaller and have decreased brain mass when compared with controls. Surprisingly, surviving neurons were found that lacked Bcl-x immunoreactivity, thereby demonstrating that this gene is dispensable for the ongoing survival of a subpopulation of catecholaminergic cells.
Key words: Parkinson; Bcl-x; catecholamine; substantia nigra; dopamine; tyrosine hydroxylase
Received Feb 24, 2005;
revised May 31, 2005;
accepted May 31, 2005.
This article has been cited by other articles:

|
 |

|
 |
 
N. Arbour, J. L. Vanderluit, J. N. Le Grand, A. Jahani-Asl, V. A. Ruzhynsky, E. C. C. Cheung, M. A. Kelly, A. E. MacKenzie, D. S. Park, J. T. Opferman, et al.
Mcl-1 Is a Key Regulator of Apoptosis during CNS Development and after DNA Damage
J. Neurosci.,
June 11, 2008;
28(24):
6068 - 6078.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|